3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Prostatic Neoplasms
5
Stomatitis
1
Stage III Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v6 and v7
1
Squamous Cell Carcinoma of Head and Neck
1
Squamous Cell Cancer of Head and Neck (SCCHN)
1
Recurrence
1
Radiation Injuries
1
Prostate Cancer Metastatic
1
Prostate Adenocarcinoma
1
Pelvic Neoplasms
1
Oropharyngeal Neoplasms
1
Neoplasm Metastasis
1
Nasopharyngeal Carcinoma
1
Mouth Neoplasms
1
Lymphatic Metastasis
1
Lung Neoplasms
1
Laryngeal Neoplasms
1
Hypopharyngeal Neoplasms
1
Head and Neck Neoplasms
1
Disease Progression
1
Carcinoma
1
Adenocarcinoma
1
Interventions
Radiosurgery
3
Androgen Antagonists
3
pembrolizumab
1
fludrocortisone acetate
1
enzalutamide
1
darolutamide
1
cabazitaxel
1
Radiotherapy, Image-Guided
1
Radiotherapy
1
Prednisone
1
Pluvicto
1
Lutetium-177
1
Lutetium
1
Hydrocortisone
1
Gonadotropin-Releasing Hormone
1
Docetaxel
1
Dexamethasone
1
Carboplatin
1
Abiraterone Acetate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Prostate Cancer Metastatic
×
Radiotherapy, Image-Guided
×
Clear all
NCT04983095
2026-02-17
METRO
Umeå University
Phase NA
Recruiting
118 enrolled